Clinical and epidemiological studies have suggested that Aβ accumulation occurs early in the timeline of neuropathological changes in AD, likely preceding the accumulation of tau, and subsequent neurodegeneration and cognitive decline (Jack et al., 2010; Sperling et al., 2011). The gene discussed is MAPT; the disease is Mental deterioration.